Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Somatic mutations, acetylator status, and prognosis in colorectal cancer.

Gut - 1 May 1998

Hardingham J E, Butler W J, Roder D, Dobrovic A, Dymock R B, Sage R E, Roberts-Thomson I C

Abstract excerpt

BACKGROUND: Somatic mutations in K-ras and TP53 may be associated with both acetylator status and prognosis in colorectal cancer. AIMS: To determine whether cancers with somatic mutations are more frequent in fast acetylators and whether mutations or acetylator status influence prognosis after colorectal surgery. PATIENTS: One hundred consecutive subjects undergoing elective surgery for colorectal cancer....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Genes, p53
Share to Genes, ras

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Staging

Share to Polymerase Chain Reaction

Share to Polymorphism, Single-Stranded Conformational

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 9659162
DOI: 10.1136/gut.42.5.669
PMCID: PMC1727095

Genes

NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Somatic mutations, acetylator status, and prognosis in colorectal cancer.PMID 9659162Read ↗

NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.Semantic proximity Read ↗

N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer.Semantic proximity Read ↗

N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review.Semantic proximity Read ↗

N-acetyltransferase polymorphism and risk of colorectal adenoma and cancer: a pooled analysis of variations from 59 studies.Semantic proximity Read ↗

Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies.Semantic proximity Read ↗

Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk.Semantic proximity Read ↗

N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.Semantic proximity Read ↗

NAT2 polymorphisms and sporadic colorectal cancer survival.Semantic proximity Read ↗

Diet, acetylator phenotype, and risk of colorectal neoplasia.Semantic proximity Read ↗

NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer.Semantic proximity Read ↗

Relation between the occurrence of K-ras gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas.Semantic proximity Read ↗

Role of acetylation in colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.